Answer
Yes, TEPEZZA (teprotumumab) is contraindicated during pregnancy because it may cause congenital malformations, including foetal growth retardation and developmental anomalies.
Sources for this answer
- TEPEZZA 500 mg powder for concentrate for solution for infusionAmgen Ltd · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 1Document updated
Sources checked